Mesoblast Limited vs Palo Alto Networks Inc — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Palo Alto Networks Inc trades at $382.27 (market cap $312.80B). The key difference: Palo Alto Networks Inc is far larger — about 141.5× Mesoblast Limited's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| MESO | PANW | |
|---|---|---|
Market Cap | $2.21B | $312.80B |
Sector | Technology | Technology |
52-Week High | $20.96 | $385.04 |
52-Week Low | $12.88 | $141.67 |
Enterprise Value | $2.21B | $311.76B |
Trailing returns across standard periods
Latest headlines on both assets
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →